Market revenue in 2023 | USD 5,277.5 million |
Market revenue in 2030 | USD 13,394.7 million |
Growth rate | 14.2% (CAGR from 2023 to 2030) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & kits |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & kits, Services |
Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 61.15% in 2023. Horizon Databook has segmented the Europe genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
Growing prevalence of cardiovascular disorders and genetic disorders coupled with increasing investments in genotyping research is expected to contribute to market growth. However, the current European economic crisis and presence of uneven reimbursement policies may restrain market growth.
In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of genotyping and diagnostic devices.
Furthermore, introduction of novel products and increasing importance of SNP genotyping in drug development are among major factors responsible for market growth. Increasing government funding, genetic counseling program by government, and growing investments in healthcare sector are some of the high-impact rendering drivers in Europe.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe genotyping market , including forecasts for subscribers. This continent databook contains high-level insights into Europe genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account